ATE550040T1 - Polymer-klebematrix mit salifizierten carboxylgruppen für die transdermale anwendung - Google Patents

Polymer-klebematrix mit salifizierten carboxylgruppen für die transdermale anwendung

Info

Publication number
ATE550040T1
ATE550040T1 AT05763405T AT05763405T ATE550040T1 AT E550040 T1 ATE550040 T1 AT E550040T1 AT 05763405 T AT05763405 T AT 05763405T AT 05763405 T AT05763405 T AT 05763405T AT E550040 T1 ATE550040 T1 AT E550040T1
Authority
AT
Austria
Prior art keywords
carboxyl groups
polymer adhesive
adhesive matrix
transdermal use
salified
Prior art date
Application number
AT05763405T
Other languages
English (en)
Inventor
Paola Stefanelli
Alberto Scarsetto
Grigoli Maurizio Di
Pierbruno Romelli
Original Assignee
Bouty S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bouty S P A filed Critical Bouty S P A
Application granted granted Critical
Publication of ATE550040T1 publication Critical patent/ATE550040T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593Polyesters, e.g. PLGA or polylactide-co-glycolide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05763405T 2004-08-06 2005-07-06 Polymer-klebematrix mit salifizierten carboxylgruppen für die transdermale anwendung ATE550040T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001628A ITMI20041628A1 (it) 2004-08-06 2004-08-06 Sistema terapeutico a rilascio controllato per uso topico transdermico
PCT/EP2005/007293 WO2006012966A1 (en) 2004-08-06 2005-07-06 Polymeric adhesive matrix with salified carboxylic groups for transdermal use

Publications (1)

Publication Number Publication Date
ATE550040T1 true ATE550040T1 (de) 2012-04-15

Family

ID=35149597

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05763405T ATE550040T1 (de) 2004-08-06 2005-07-06 Polymer-klebematrix mit salifizierten carboxylgruppen für die transdermale anwendung

Country Status (14)

Country Link
US (3) US20080292708A1 (de)
EP (1) EP1784169B1 (de)
JP (1) JP2008509096A (de)
CN (1) CN101001616B (de)
AT (1) ATE550040T1 (de)
AU (1) AU2005268981B2 (de)
CA (1) CA2576087A1 (de)
ES (1) ES2387200T3 (de)
IT (1) ITMI20041628A1 (de)
MX (1) MX2007001560A (de)
PL (1) PL1784169T3 (de)
PT (1) PT1784169E (de)
RU (1) RU2401126C2 (de)
WO (1) WO2006012966A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002250293B2 (en) 2001-03-09 2007-10-11 Arnason, Barry G. Mr Polymeric immunoglobulin fusion proteins that target low-affinity FCGammaReceptors
ES2608782T3 (es) 2010-04-30 2017-04-17 Teikoku Pharma Usa, Inc. Composiciones transdérmicas de propinilaminoindano
EP2688561B1 (de) 2011-03-24 2018-08-22 Teikoku Pharma USA, Inc. Transdermale zusammensetzungen mit einer wirkstoffschicht und einer wirkstoffumwandlungsschicht
JP5913614B2 (ja) 2011-11-09 2016-04-27 テイコク ファーマ ユーエスエー インコーポレーテッド 皮膚新生物の処置方法
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
AU2013338243B2 (en) 2012-11-02 2016-09-29 Teikoku Seiyaku Co., Ltd. Propynylaminoindan transdermal compositions
US9962349B2 (en) 2014-10-17 2018-05-08 Fidia Farmaceutici S.P.A. Dermal therapeutic system with high adhesivity
CN115813888A (zh) 2016-12-20 2023-03-21 罗曼治疗系统股份公司 包含阿塞那平的透皮治疗系统
EP3558276B1 (de) 2016-12-20 2024-11-06 LTS Lohmann Therapie-Systeme AG Transdermales therapeutisches system mit asenapin und polysiloxan oder polyisobutylen
WO2019002204A1 (en) 2017-06-26 2019-01-03 Lts Lohmann Therapie-Systeme Ag TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE AND SILICONE-TYPE ACRYLIC HYBRID POLYMER
AU2019291060B2 (en) 2018-06-20 2024-09-05 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
US12329862B2 (en) 2018-06-20 2025-06-17 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
KR102068595B1 (ko) * 2018-08-06 2020-01-21 고세윤 생체의료용 고분자를 포함하는 체온 감응형 점착제 조성물 및 이를 이용한 점착시트

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58103317A (ja) 1981-12-12 1983-06-20 Nitto Electric Ind Co Ltd ヒドロゾル製剤
CH643138A5 (de) * 1983-08-29 1984-05-30 Mepha Ag Indomethacin enthaltende, gelartige salbe.
JPS6229516A (ja) * 1985-07-30 1987-02-07 Nitto Electric Ind Co Ltd 医薬製剤
DE3901551A1 (de) * 1989-01-20 1990-07-26 Lohmann Therapie Syst Lts Superfizielles therapeutisches system mit einem gehalt an einem antineoplastischen wirkstoff, insbesondere 5-fluoruracil
DE3913734C2 (de) * 1989-04-26 1998-08-20 Roehm Gmbh Verwendung einer wäßrigen Hauthaftkleberlösung zur Herstellung einer mit Wasser leicht abwaschbaren Klebschicht
US5041287A (en) * 1989-05-22 1991-08-20 Terry L. Driggers Sprayable composition using acetone solvent
DE4238223C1 (de) * 1992-11-12 1994-05-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung
FR2709770B1 (fr) 1993-09-10 1995-10-13 Peller Entr Mur de soutènement ou anti-bruit.
FR2719770A1 (fr) * 1994-05-11 1995-11-17 Lhd Lab Hygiene Dietetique Système matriciel pour administration transdermique d'ibuprofène et procédé de préparation.
DE4429791C2 (de) 1994-08-23 1997-04-24 Lohmann Therapie Syst Lts Medizinischer Haftkleber auf Basis von Polyacrylaten und dessen Verwendung
AU3470600A (en) * 1999-01-14 2000-08-01 David Houze Compositions and methods for drug delivery
DE19918106A1 (de) * 1999-04-22 2000-10-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern
US6645520B2 (en) * 1999-12-16 2003-11-11 Dermatrends, Inc. Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
US6562369B2 (en) * 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of androgenic drugs hydroxide-releasing agents as permeation enhancers
DE10035891A1 (de) * 2000-07-24 2002-02-14 Lohmann Therapie Syst Lts Medizinischer Haftkleber mit einer zweiphasigen Klebermatrix aus Polyacrylaten und Polyaminsalzen
DE10110391A1 (de) 2001-03-03 2002-09-26 Lohmann Therapie Syst Lts Hochflexibles Nikotin transdermales therapeutisches System mit Nikotin als Wirkstoff
ITMI20020798A1 (it) * 2002-04-15 2003-10-15 F T Holding S A Cerotti transdermici a matrice adesiva siliconica stabilizzati con copolimeri metacrilici

Also Published As

Publication number Publication date
US20140080911A1 (en) 2014-03-20
US10328034B2 (en) 2019-06-25
PL1784169T3 (pl) 2012-08-31
AU2005268981A1 (en) 2006-02-09
EP1784169A1 (de) 2007-05-16
WO2006012966A1 (en) 2006-02-09
US20170128383A1 (en) 2017-05-11
AU2005268981B2 (en) 2010-05-13
JP2008509096A (ja) 2008-03-27
EP1784169B1 (de) 2012-03-21
PT1784169E (pt) 2012-06-26
RU2401126C2 (ru) 2010-10-10
AU2005268981A2 (en) 2006-02-09
CN101001616B (zh) 2010-06-16
ITMI20041628A1 (it) 2004-11-06
RU2007104354A (ru) 2008-08-10
MX2007001560A (es) 2008-03-05
ES2387200T3 (es) 2012-09-17
CA2576087A1 (en) 2006-02-09
US20080292708A1 (en) 2008-11-27
CN101001616A (zh) 2007-07-18

Similar Documents

Publication Publication Date Title
ATE550040T1 (de) Polymer-klebematrix mit salifizierten carboxylgruppen für die transdermale anwendung
AR072492A1 (es) Dispositivo y administracion transdermica de estrogeno
AR095259A1 (es) Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria
DK2029121T3 (da) Transdermalt terapeutisk system indeholdende partikler af virksom bestanddel og med forøget strøm af virksom bestanddel
HRP20090209T1 (hr) Proizvodnja uređaja za dugotrajno oslobađanje lijeka sa polimerima na bazi poliuretana
EP2589379A4 (de) Transdermales wirkstofffreisetzungssystem mit donepezil
NO20082988L (no) Vedvarende frigivningsformulering innbefattende oktreotid og to eller flere polylaktid-ko-glykolidpolymerer
CR20110373A (es) Preparación de liberación controlada (divisional solicitud n° 10284)
CY1112582T1 (el) Διαδερμικη χορηγηση φεντανυλης
HRP20110861T1 (hr) Lijek za liječenje gripe
ATE455541T1 (de) Transdermales therapeutisches system (tts) mit dem wirkstoff fentanyl
ECSP11011199A (es) Formulación de depósito de octreotida con niveles de exposición constantemente altos
AR094290A1 (es) Composiciones y metodos para la administracion transdermica de agentes antiinflamatorios no esteroideos
IT1257793B (it) Composizione farmaceutica a base di acidi biliari in microgranuli a rilascio controllato
AR095260A1 (es) Composiciones de anfetaminas transdérmicas estables y métodos de fabricación
DE60100937D1 (de) Pflaster für die lokale und transdermale verabreichung von wirkstoffen mit anionischen oder elektronen-anziehenden gruppen
EP3805200A4 (de) Selbstassembliertes supramolekulares aminosäurepolymer, dessen herstellung und verwendung
NO20073457L (no) Stabile sammensetninger av fenofibrat med fettsyreestere
DE59900497D1 (de) Transdermales therapeutisches system (tts) oxybutynin enthaltend
DK1529041T3 (da) Nye prodrugs af 1-methyl-2-(4-amidinophenylaminomethyl)benzimidazol-5-ylcarboxylsyre-(N-2-pyridyl-N-2-hydroxycarbonylethyl)amid, fremstilling af disse samt anvendelse af disse som lægemiddel
AR103296A2 (es) Tableta o gránulo donde la liberación del ingrediente activo es controlada
MXPA01008785A (es) Composicion farmaceutica para el tratamiento de afecciones que cursan con inflamacion y/o dolor mediante la administracion transdermica de antiinflamatorios no esteroides incorporados en matrices polimericas acrilicas adhesivas.
DK1143938T3 (da) Transdermalt terapeutisk system med en selvklæbende matrix, der indeholder organiske syreadditionssalte af alkaloider af morphin- eller morphin-type
BR0313092A (pt) Sistema de liberação transdérmica aperfeiçoado
AR048342A1 (es) FORMAS DE DOSIFICACIoN FARMACÉUTICAS QUE COMPRENDEN EL ÁCIDO N-(2-(2-FTALIMIDOETOXI)-ACETIL)-L-ALANIL-D-GLUTÁMICO (LK-423)